Quoin finalizes CFO exit: $433K lieu of notice, $108K bonus, extended options

Quoin Pharmaceuticals, Ltd.

Separation agreement signed August 21; effective August 15, 2025.
Dunn receives $433,620 in bi-weekly installments in lieu of 12 months' notice.
Additional $108,405 bonus for FY2024 paid in lump sum after 12 months.
Vested stock options post-termination exercise period extended to 1 year 9 months from 90 days.
Agreement includes mutual release of claims; no admission of liability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.